183 related articles for article (PubMed ID: 27340429)
1. Hepatitis B and C viruses and risk of non-Hodgkin lymphoma: a case-control study in Italy.
Taborelli M; Polesel J; Montella M; Libra M; Tedeschi R; Battiston M; Spina M; Di Raimondo F; Pinto A; Crispo A; Grimaldi M; Franceschi S; Dal Maso L; Serraino D
Infect Agent Cancer; 2016; 11():27. PubMed ID: 27340429
[TBL] [Abstract][Full Text] [Related]
2. Hepatitis virus B and C infections are associated with an increased risk of non-Hodgkin lymphoma: A nested case-control study using a national sample cohort.
Kim M; Lee YK; Park B; Oh DJ; Choi HG
J Med Virol; 2020 Aug; 92(8):1214-1220. PubMed ID: 31825111
[TBL] [Abstract][Full Text] [Related]
3. Chronic Hepatitis B and C Virus Infection and Risk for Non-Hodgkin Lymphoma in HIV-Infected Patients: A Cohort Study.
Wang Q; De Luca A; Smith C; Zangerle R; Sambatakou H; Bonnet F; Smit C; Schommers P; Thornton A; Berenguer J; Peters L; Spagnuolo V; Ammassari A; Antinori A; Quiros-Roldan E; Mussini C; Miro JM; Konopnicki D; Fehr J; Campbell MA; Termote M; Bucher HC;
Ann Intern Med; 2017 Jan; 166(1):9-17. PubMed ID: 27750294
[TBL] [Abstract][Full Text] [Related]
4. Both chronic HBV infection and naturally acquired HBV immunity confer increased risks of B-cell non-Hodgkin lymphoma.
Zhou X; Pan H; Yang P; Ye P; Cao H; Zhou H
BMC Cancer; 2019 May; 19(1):477. PubMed ID: 31113483
[TBL] [Abstract][Full Text] [Related]
5. Infection with hepatitis B and C viruses and risk of lymphoid malignancies in the European Prospective Investigation into Cancer and Nutrition (EPIC).
Franceschi S; Lise M; Trépo C; Berthillon P; Chuang SC; Nieters A; Travis RC; Vermeulen R; Overvad K; Tjønneland A; Olsen A; Bergmann MM; Boeing H; Kaaks R; Becker N; Trichopoulou A; Lagiou P; Bamia C; Palli D; Sieri S; Panico S; Tumino R; Sacerdote C; Bueno-de-Mesquita B; Peeters PH; Rodríguez L; Barroso LL; Dorronsoro M; Sánchez MJ; Navarro C; Barricarte A; Regnér S; Borgquist S; Melin B; Hallmans G; Khaw KT; Wareham N; Rinaldi S; Hainaut P; Riboli E; Vineis P
Cancer Epidemiol Biomarkers Prev; 2011 Jan; 20(1):208-14. PubMed ID: 21098651
[TBL] [Abstract][Full Text] [Related]
6. The association of hepatitis B virus infection with B-cell non-Hodgkin lymphoma - a review.
Marcucci F; Spada E; Mele A; Caserta CA; Pulsoni A
Am J Blood Res; 2012; 2(1):18-28. PubMed ID: 22432084
[TBL] [Abstract][Full Text] [Related]
7. Hepatitis B virus infection and risk of non-Hodgkin lymphoma in South Korea: a cohort study.
Engels EA; Cho ER; Jee SH
Lancet Oncol; 2010 Sep; 11(9):827-34. PubMed ID: 20688564
[TBL] [Abstract][Full Text] [Related]
8. Hepatitis B virus infection and risk of lymphoma: results of a serological analysis within the European case-control study Epilymph.
Becker N; Schnitzler P; Boffetta P; Brennan P; Foretova L; Maynadié M; Nieters A; Staines A; Benavente Y; Cocco P; de Sanjose S
J Cancer Res Clin Oncol; 2012 Dec; 138(12):1993-2001. PubMed ID: 22767316
[TBL] [Abstract][Full Text] [Related]
9. High prevalence of past hepatitis B virus infection in diffuse large B cell lymphoma: a retrospective study from Italy.
Visentini M; Pica A; D'Ippolito G; Sculco E; La Gualana F; Gragnani L; Miglionico M; Mazzaro C; Fiorilli M; Basili S; Martelli M; Di Rocco A; Casato M; Gentile G; Pulsoni A
Ann Hematol; 2023 Dec; 102(12):3457-3463. PubMed ID: 37650886
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis C virus and non-Hodgkin's lymphoma: Findings from the Swiss HIV Cohort Study.
Franceschi S; Polesel J; Rickenbach M; Dal Maso L; Probst-Hensch NM; Fux C; Cavassini M; Hasse B; Kofler A; Ledergerber B; Erb P; Clifford GM
Br J Cancer; 2006 Dec; 95(11):1598-602. PubMed ID: 17106439
[TBL] [Abstract][Full Text] [Related]
11. Chronic viral hepatitis, HIV infection and Non-Hodgkin lymphomas in West Africa, a case-control study.
Jaquet A; Boni SP; Boidy K; Tine J; Tchounga B; Touré SA; Koffi JJ; Dial C; Monnereau A; Diomande I; Tanon A; Seydi M; Dabis F; Diop S; Koffi G;
Int J Cancer; 2021 Oct; 149(8):1536-1543. PubMed ID: 34124779
[TBL] [Abstract][Full Text] [Related]
12. Hepatitis B virus infection and risk of intrahepatic cholangiocarcinoma and non-Hodgkin lymphoma: a cohort study of parous women in Taiwan.
Fwu CW; Chien YC; You SL; Nelson KE; Kirk GD; Kuo HS; Feinleib M; Chen CJ
Hepatology; 2011 Apr; 53(4):1217-25. PubMed ID: 21480326
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of hepatitis B or C virus infections in patients with non-Hodgkin's lymphoma.
Kuniyoshi M; Nakamuta M; Sakai H; Enjoji M; Kinukawa N; Kotoh K; Fukutomi M; Yokota M; Nishi H; Iwamoto H; Uike N; Nishimura J; Inaba S; Maeda Y; Nawata H; Muta K
J Gastroenterol Hepatol; 2001 Feb; 16(2):215-9. PubMed ID: 11207904
[TBL] [Abstract][Full Text] [Related]
14. The impact of hepatitis B virus and hepatitis C virus infections in patients with Hodgkin's and non-Hodgkin's lymphoma.
Kadry DY; Elbahnasawy MA; Mansour MT; El Gebaly OK; Aziz H; Kamel MM; Abdel-Moneim AS; Radwan S
Int J Immunopathol Pharmacol; 2023; 37():3946320231207342. PubMed ID: 37859403
[TBL] [Abstract][Full Text] [Related]
15. microRNA levels in paraffin-embedded indolent B-cell non-Hodgkin lymphoma tissues from patients chronically infected with hepatitis B or C virus.
Bruni R; Marcantonio C; Pulsoni A; Tataseo P; De Angelis F; Spada E; Marcucci F; Panfilio S; Bianco P; Riminucci M; Villano U; Tosti M; Ciccaglione A; Mele A
BMC Infect Dis; 2014; 14 Suppl 5(Suppl 5):S6. PubMed ID: 25236768
[TBL] [Abstract][Full Text] [Related]
16. Rituximab increases the risk of hepatitis B virus reactivation in non-Hodgkin lymphoma patients who are hepatitis B surface antigen-positive or have resolved hepatitis B virus infection in a real-world setting: a retrospective study.
Tsai YF; Yang CI; Du JS; Lin MH; Tang SH; Wang HC; Cho SF; Liu YC; Su YC; Dai CY; Hsiao HH
PeerJ; 2019; 7():e7481. PubMed ID: 31565551
[TBL] [Abstract][Full Text] [Related]
17. Non-Hodgkin's lymphoma and hepatitis C virus: a case-control study from northern and southern Italy.
Talamini R; Montella M; Crovatto M; Dal Maso L; Crispo A; Negri E; Spina M; Pinto A; Carbone A; Franceschi S
Int J Cancer; 2004 Jun; 110(3):380-5. PubMed ID: 15095303
[TBL] [Abstract][Full Text] [Related]
18. Risk of Reverse Seroconversion of Hepatitis B Virus Surface Antigen in Rituximab-Treated Non-Hodgkin Lymphoma Patients: A Large Cohort Retrospective Study.
Hsiao LT; Chiou TJ; Gau JP; Yang CF; Yu YB; Liu CY; Liu JH; Chen PM; Tzeng CH; Chan YJ; Yang MH; Huang YH
Medicine (Baltimore); 2015 Aug; 94(32):e1321. PubMed ID: 26266374
[TBL] [Abstract][Full Text] [Related]
19. High incidence of hepatitis B virus infection in B-cell subtype non-Hodgkin lymphoma compared with other cancers.
Wang F; Xu RH; Han B; Shi YX; Luo HY; Jiang WQ; Lin TY; Huang HQ; Xia ZJ; Guan ZZ
Cancer; 2007 Apr; 109(7):1360-4. PubMed ID: 17326056
[TBL] [Abstract][Full Text] [Related]
20. [An analysis of hepatitis B virus infection rate in 405 cases of non-Hodgkin lymphoma].
Liu WP; Zheng W; Wang XP; Song YQ; Xie Y; Tu MF; Lin NJ; Ping LY; Ying ZT; Deng LJ; Zhang C; Zhu J
Zhonghua Xue Ye Xue Za Zhi; 2011 Aug; 32(8):521-4. PubMed ID: 22338173
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
